70NANB22H006
Cooperative Agreement
Overview
Grant Description
Title: Accelerated Modular Process Development (AMPD) for Domestic Manufacturing of Critical Active Pharmaceutical Ingredient Chemical Precursors
Purpose:
The purpose of this grant is to develop a more efficient framework for domestic manufacturing of active pharmaceutical ingredients (APIs) critical to a more effective coronavirus response.
Activities to be Performed:
The project team will define a new streamlined approach to take a chemical manufacturing process from lab bench to commercial production. The project will also develop a work process that incorporates historic best practices, updated with state-of-the-art technical, economic, and sustainability modeling, and integrates the approaches to modular manufacturing. A Process Development Center of Excellence will be established as a testbed where researchers can access state-of-the-art laboratory and modular pilot plant systems for developing and scaling chemical manufacturing processes.
Expected Outcomes:
The project will build greater resilience in supply chains for active pharmaceutical ingredients (APIs) through intensified, modular processes.
Intended Beneficiaries:
Small and medium manufacturers will benefit from the use of the Center of Excellence to develop processes and build production capacity for onshoring of selected specialty chemicals, API precursors, and APIs.
Subrecipient Activities:
The recipient plans to subaward funds to bring together experts in chemical and pharmaceutical process development and modular processing technology to be an integral part of this research project.
Purpose:
The purpose of this grant is to develop a more efficient framework for domestic manufacturing of active pharmaceutical ingredients (APIs) critical to a more effective coronavirus response.
Activities to be Performed:
The project team will define a new streamlined approach to take a chemical manufacturing process from lab bench to commercial production. The project will also develop a work process that incorporates historic best practices, updated with state-of-the-art technical, economic, and sustainability modeling, and integrates the approaches to modular manufacturing. A Process Development Center of Excellence will be established as a testbed where researchers can access state-of-the-art laboratory and modular pilot plant systems for developing and scaling chemical manufacturing processes.
Expected Outcomes:
The project will build greater resilience in supply chains for active pharmaceutical ingredients (APIs) through intensified, modular processes.
Intended Beneficiaries:
Small and medium manufacturers will benefit from the use of the Center of Excellence to develop processes and build production capacity for onshoring of selected specialty chemicals, API precursors, and APIs.
Subrecipient Activities:
The recipient plans to subaward funds to bring together experts in chemical and pharmaceutical process development and modular processing technology to be an integral part of this research project.
Grant Program (CFDA)
Awarding / Funding Agency
Place of Performance
New York,
New York
10005-4020
United States
Geographic Scope
Single Zip Code
Related Opportunity
None
Analysis Notes
COVID-19 $4,638,882 (100%) percent of this Cooperative Agreement was funded by COVID-19 emergency acts including the American Rescue Plan Act of 2021.
Amendment Since initial award the End Date has been extended from 02/29/24 to 08/31/24.
Amendment Since initial award the End Date has been extended from 02/29/24 to 08/31/24.
American Institute Of Chemical Engineers was awarded
AMPD for Domestic Manufacturing of Critical API Chemical Precursors
Cooperative Agreement 70NANB22H006
worth $4,638,882
from the National Institute of Standards and Technology in March 2022 with work to be completed primarily in New York New York United States.
The grant
has a duration of 2 years 5 months and
was awarded through assistance program 11.619 Arrangements for Interdisciplinary Research Infrastructure.
Status
(Complete)
Last Modified 12/20/23
Period of Performance
3/1/22
Start Date
8/31/24
End Date
Funding Split
$4.6M
Federal Obligation
$0.0
Non-Federal Obligation
$4.6M
Total Obligated
Activity Timeline
Subgrant Awards
Disclosed subgrants for 70NANB22H006
Transaction History
Modifications to 70NANB22H006
Additional Detail
Award ID FAIN
70NANB22H006
SAI Number
70NANB22H006_1
Award ID URI
EXE
Awardee Classifications
Nonprofit With 501(c)(3) IRS Status (Other Than An Institution Of Higher Education)
Awarding Office
1333ND DEPT OF COMMERCE NIST
Funding Office
1333ND DEPT OF COMMERCE NIST
Awardee UEI
KLPNCLPDAS45
Awardee CAGE
46810
Performance District
NY-10
Senators
Kirsten Gillibrand
Charles Schumer
Charles Schumer
Budget Funding
| Federal Account | Budget Subfunction | Object Class | Total | Percentage |
|---|---|---|---|---|
| Industrial Technology Services, National Institute of Standards and Technology, Commerce (013-0525) | Other advancement of commerce | Grants, subsidies, and contributions (41.0) | $4,638,882 | 100% |
Modified: 12/20/23